test

Fan Yu

@Ally Bridge Group (ny) Llc

Latest period2024 - Q3ReportedManaged Assets$186.813MTotal holdings29
Assets growth rate11.3%Assets growth rate (2-Q avg)2.31%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Ally Bridge Group (ny) Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 29 positions.

Assets under management

The assets under management (AUM) of Ally Bridge Group (ny) Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 186.813M in assets, with a quarterly growth rate of 11.3% and a 2-quarter average growth rate of 2.31%. The portfolio is managed by Fan Yu, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
TARSTarsus Pharmaceuticals Inc
Recent Activity
New Position
5.67%
$10.587M
321,898 shares@ $32.89 avg price
RVMDRevolution Medicines Inc
Recent Activity
New Position
3.97%
$7.415M
163,500 shares@ $45.35 avg price
SWTXSpringworks Therapeutics Inc
Recent Activity
New Position
3.91%
$7.296M
227,700 shares@ $32.04 avg price
ELVNEnliven Therapeutics Inc
Recent Activity
New Position
3.22%
$5.998M
234,856 shares@ $25.54 avg price
APLTApplied Therapeutics Inc
Recent Activity
New Position
2.82%
$5.256M
618,332 shares@ $8.5 avg price
EWTXEdgewise Therapeutics Inc
Recent Activity
New Position
2.69%
$5.01M
187,695 shares@ $26.7 avg price
CNTACentessa Pharmaceuticals
Recent Activity
New Position
2.66%
$4.951M
309,614 shares@ $16.0 avg price
JANXJanux Therapeutics Inc
Recent Activity
New Position
2.65%
$4.943M
108,811 shares@ $45.44 avg price
RLAYRelay Therapeutics Inc
Recent Activity
New Position
2.38%
$4.432M
626,058 shares@ $7.09 avg price